WE ARE HELPING 25,000 CHILDREN WITH AUTISM. YOUR DONATION WILL GIVE HOPE TO MANY MORE KIDS WITH ASD WORLDWIDE


Share this campaign

Help raise awareness for this campaign by sharing this widget. Simply paste the following HTML code most places on the web.

Embed Code

<iframe src="https://crowd.science/campaigns/autism/?widget=1" width="260px" height="500px" frameborder="0" scrolling="no" /></iframe>

MITA is a gamified therapy for children with autism. We are raising funds to help us scientifically analyse the benefits to children with autism to give parents and carers accurate information on expected benefits. 

Autism affects people of any race or economic status. About 1 in 68 children born today will be identified with autism spectrum disorder according to the Centers for Disease Control and Prevention (CDC).

With no genetic test to predict the disease, the main focus is to assist children in reaching their full potential. Unfortunately, approximately half of children diagnosed with autism are failed by the current system  and end up with a condition known as low-functioning autism.  The ImagiRation team and I, Dr. Andrey Vyshedskiy  are trying to change this statistic.

One of the main reasons these children become low-functioning is a lack of development in their language processing skills. Research has shown that early childhood is the most critical time for developing language. Missing this key period may result in a permanent inability for a person to understand complex language including syntax, spatial prepositions, and verb tenses. Our team at ImagiRation has developed Mental Imagery Therapy for Autism (MITA), an application for children with autism that allows parents to administer early-intervention therapy as early as possible and in the comfort of their own home.

We also recently did a TED-Ed video explaining a bit more about how the child brain develops. See below:

Over the past year, we have succeeded in getting MITA into the hands of over 25,000 kids with autism to use as a supplement to their regular therapy. MITA is designed for early childhood and intended for long-term, daily use. Its bright, interactive exercises are based on therapeutic techniques that have been shown to be effective for individuals with autism.

Mrs. Amber Bonasse started administering MITA to her son, who was diagnosed with autism before he turned 3.  “I have tried many things for my son, even before the diagnosis to no avail… One of the most profound changes came after he started the MITA program… I was able to definitively see a major difference in him and his ability to problem solve and process,” she writes.

MITA in the news:

SUPPORT THE BIGGEST AUTISM RESEARCH TRIAL IN HISTORY

Our goal with this campaign is to gain funding to study and evaluate the extensive data we’ve collected on children who have been working with MITA. Every three months, parent of MITA users are asked to complete a diagnostic questionnaire. This diagnostic information, along with anonymous data from the application, is used to measure the effectiveness of the MITA therapy. We have now accumulated 12 months’ worth of data and require funding to analyze and publish our first findings. We ask you to help us in this process – every donation will be put towards us analysing the data we have collected, in order to enable us to provide parents with accurate information on the benefits of MITA based on scientific evidence.

Working with a child with autism requires hard work and patience. We want to prove to current and future families that sticking to the MITA therapy will help their kids make remarkable strides in language acquisition along with a wide range of other skills. Through our observations so far the data we have reviewed suggests that MITA is helping children who use the app regularly develop faster.

THE SCIENCE BEHIND MITA

MITA is based on Pivotal Response Treatment (PRT), one of the best-supported therapies for children diagnosed with ASD. The exercises target three of four critical areas of development supported by PRT:  response to multiple cues, motivation, and self-management.

A child’s ability to notice and to respond to multiple visual cues presented simultaneously is the most critical. This ability is typically impaired in individuals with autism, leading to what is commonly described as “stimulus overselectivity,” or “tunnel vision.” Improving the capacity to respond to multiple cues has been shown to reduce stimulus overselectivity, which in turn leads to vast improvements in general learning.

A peer-reviewed article describing MITA: http://goo.gl/lyHw95

MITA GAMES

MITA includes nine adaptive games that develop a child’s mental-integration ability as well as train their language functions. The visual exercises follow a systematic approach for developing a child’s ability to notice multiple characteristics of an object. MITA starts with simple exercises that teach a child to attend to only one feature, such as size or color. Over time, the exercises get more difficult and require the child to attend to two features simultaneously, such as both color and size. In order to solve these puzzles, a child must learn how to hold two pieces of information in their mind (both the size and the color of an object) and make a decision based on the combination of these features. Once a child has practiced attending to two features, the program moves on to puzzles that require attending to three features, such as color, size and shape, and then eventually to puzzles that involve attending to an ever-increasing number of characteristics.

The verbal exercises (labelled the Language Game) in MITA also train your child’s mental integration ability. However, these puzzles offer a more conventional, verbal approach to facilitating language acquisition, starting with simple vocabulary, and progressing towards higher forms of language (such as adjectives, prepositions, and syntax).

As a child progresses through MITA’s systematic exercises, he or she is developing the ability to simultaneously attend to a greater number of features, reducing the propensity towards tunnel vision, and thus developing an essential component of language. The ability to mentally build an image based on a combination of multiple features is absolutely necessary for understanding syntax, spatial prepositions and verb tenses.

MITA is available in the Apple Store, Google Play, and Amazon App Store. It is absolutely free and we want to keep it free.

TEAM

Dr. Andrey Vyshedskiy

av_photo_500x468

Andrey Vyshedskiy, Ph.D., is the Founder and CEO of ImagiRation LLC. Dr. Vyshedskiy was trained in neuroscience, biomedical engineering, and astrophysics. He received a Ph.D. in Neuroscience from Boston University, and has conducted research in neuroscience, cardiopulmonary acoustics, and optical vibrometry. He has co-founded several successful companies, received numerous awards from the NSF, the NIH, and the DOD, and directed the development of several FDA approved medical devices. He has been teaching Human Physiology, Neuroscience, and Neurobiology of Consciousness to BU students for over two decades. He has also periodically taught Tufts Medical School students. He has authored over 100 scientific publications, book chapters, and conference presentations. His work has appeared in the New England Journal of Medicine, Thorax, Chest, the Journal of Neuroscience and other leading scientific journals. Dr. Vyshedskiy currently lives in Boston with his wife and two children.

Jonah Elgart

jonah_headshot

Jonah Elgart serves as Art Director for ImagiRation LLC. Mr. Elgart received a Bachelors of Science from MIT. He has designed, animated, illustrated, and programmed educational software for over ten years. In his work, he fuses a quirky child-like sense of humor with a conceptual interest in learning. The end product is innovative software that uses intuitive affordances to make learning natural and engaging. Mr. Elgart’s work straddles research and commercial projects, and he has worked with clients including Harvard University’s EdX platform, Columbia University School of Education, PBS, and Pearson. He has also launched several children’s apps under his own brands.

Rita Dunn

ritapic2

Rita Dunn, M.A., is the Founder and Chief Scientific Officer of ImagiRation LLC. Mrs. Dunn has received a Master of Arts degree in Math Education from Harvard University. She has been working for over a decade as an educator devoted to honing the cognitive skills of both neurotypical and developmentally-delayed kids. Her years of experience informed her that proper, early instruction utilizing building blocks, educational manipulatives, puzzles and games can have a profound effect on the development of a child. She also saw, firsthand, that there is a shortage of materials that are appropriately designed for use with individuals with developmental disorders, the population that has the most to benefit from proper developmental training. For Mrs. Dunn, the ImagiRation project is a culmination of over a decade of education, research and practical experience that has led her to conclude that brain training can and will have a profound effect on kids with developmental disorders such as ASD.

Lisa Lokshina

lisalokshin

Lisa Lokshina is Co-founder and Director of User Experience of ImagiRation LLC.  Mrs. Lokshina has received a Masters degree in Interaction Design from New York University and a Bachelor of Science in Journalism from Boston University. Mrs. Lokshina brings to ImagiRation extensive experience in digital design and user research as well as an outstanding journalistic talent.

Alex Faisman

alexfaisman

Alexander Faisman, is the Co-founder and Chief Software Architect of ImagiRation. Mr. Faisman has over 20 years of experience in software development in companies such as  Moody’s, Morgan Stanley, Venado Technologies, and PRI Automation. Mr. Faisman brings to ImagiRation essential software experience and profound dedication to the education of children.

In addition to this wonderful team, we are working with a group of award-winning artists and developers alongside experienced therapists and researchers.

For more information, please visit www.imagiration.com or contact us at imagiration@gmail.com.

Endorsements

Monica R. Meyer, MD
Developmental-Behavioral Pediatrician

I am very excited to learn about your research project to provide parents of young children with autism with a tool for enhancing their children’s development.

As a developmental-behavioral pediatrician, I frequently make the diagnosis of autism. Parents often want to know what they can do to support their child – in additions to arranging for various therapies and special instruction. As you know, it is so important to begin treatment as early as possible. An initiative that can enable parents to make a significant difference in the lives of their children with autism will be doubly rewarding.

I enthusiastically offer my support to your research project.

Amber Bonasse
Parent of child with autism

My son Alexander who turned 3 in September, was recently diagnosed with Autism Spectrum Disorder. He went through all the testing; in school, with diagnosticians and with therapist and though I knew he was a very bright boy, his scores on were very low. Once I got the diagnosis, I started looking for answers or anything that might help my son. Fortunately, I found the Mental Imagery therapy for Autism (MITA) program.

One of the most challenging problems I encounter when trying treatments for my son is keeping his attention. Most programs he only uses for a moment and then quickly moves on, refusing to try the program again. With MITA, he stays interested for a long time. Most of the time, I’m the one trying to get him to take a break from it! Aside from offering a multitude of changing pictures and puzzles, they quite thoughtfully also change the format of the puzzles; from orientation of the puzzles to the types of puzzles being solved which helps keep it interesting. Giving the instant praise after solving a puzzle as well as the big “Play Time” reward is a huge help as well. He jumps up out of his chair and is so excited every time he solves a puzzle and makes it very special.

What’s also wonderful about this program, is being able to see the change in him. To be able to see him think about and solve the puzzles, something he wasn’t able to do a few months ago is astonishing. Puzzles and other cognitive activities were a very big area of opportunity for him, but within the first week I was able to definitively see a major difference in him and his ability to problem solve and process.

I have tried many things for my son, even before the diagnosis to no avail. But I have no doubt that one of the most profound changes came after he started the MITA program and I’m so thankful that I found it. The MITA App is giving my son a beginning and a chance and for that, I can’t thank ImagiRation Inc enough.

Kimberly Vanaman 
Behavioural TherapistMemorial-Spaulding Elementary School

Thank you for the opportunity to meet with you and your team to experience and discuss your ImagiRation Program in regards to its benefits to children with Autism as well as the neuro-typical population. I was very impressed with the superior caliber of the scientific research and thoughtfulness behind the program. The high quality of the visuals and the intellectual investment was clearly apparent in this program’s creation and design.  It was a lively, informative and exciting exchange of information and ideas and I would very much like to see your research and development continue.

I have the perspective of 15 years experience at the elementary public education level, frequently working with children challenged by Autism. I recognized the appeal, educational value and facile access that your program offers to the population within my scope.  The “no-explanation-needed” design of your program carries particular interest, as the students I work with frequently find understanding of instructions extremely challenging.

After our meeting, I offered your program to several of my students and was pleased to see them able to navigate its operations easily and move through the levels with interest and enthusiasm. I observed that the increase in difficulty was subtle and gradual and therefore generally avoided frustration. The reinforcement portion of the program when a puzzle was completed was very suitable and particularly appealing to the learning challenged group I instruct.

Congratulations on your success thus far and best wishes for your continued development of your ImagiRation Program.

Igor Rozenwald
Medical Doctor

As a medical doctor and father of a son diagnosed with autism, I am eager to support this research. ImagiRation has already proven itself to be an effective research and development group for digital interventions for kids with ASD. My son, who was diagnosed with autism at the age of 3, has shown much success with ImagiRation’s MITA application, which he has been using for over a year. MITA has provided him with thousands of puzzle-like exercises tailored to his ability level. I was excited to see his interest and continuous engagement with the program and believe it is an effective component to his ongoing treatment.

I offer my full support on this exciting and important project.

Helen Tager-­‐Flusberg, Ph.D.
Professor, Psychological & Brain Sciences, Boston University
Professor, Anatomy & Neurobiology and Pediatrics, Boston University School of Medicine Joint Appointment, Sargent College, Boston University.

This is to confirm my support for your research project developing an early intervention iPad app for children with autism spectrum disorder. As you know, it is very important to commence therapy as early as possible. An app that helps parents begin early intervention may have significant potential to improve outcomes.

My research interests in language acquisition in children with autism spectrum disorder spans over three decades. As a director of Boston University Center for Autism Research Excellence I am currently involved in studies of infants at risk for ASD, verbal children and adolescents with ASD and minimally verbal children with ASD (in collaboration with colleagues at BU, MIT, Harvard Medical School, Boston Children’s Hospital, MGH, Beth Israel Deaconess Medical Center and Northeastern). Furthermore, I have been very interested in developing an app for older minimally verbal children with autism, but lack the technical skills and time! I am pleased to support your efforts in providing guidance on the language component of MITA that will serve preverbal children with ASD as part of the more comprehensive curriculum you are developing.

 I have seen ImagiRation’s existing app and was impressed by its thoughtful design, attractive artwork and sleek performance. I look forward to collaborating with the ImagiRation team on this exciting and very important project.

Eric London, Medical Doctor
Director of the Autism Treatment Research Lab
NYS Institute for Basic Research in Developmental Disabilities

I am writing this letter in support of the MITA application -an early intervention application of children with ASD. This application is addressing many of the most important deficits in our current ability to treat ASD. Simple to use and available interventions to the very young is extremely important. Too often affected children must wait for lengthy evaluations and often nonexistent intervention programs. This program address that issue through the use of technology and parent training to use it. Their methods are taken from the well proven applied behavior analysis methods and so can be used as an adjunct to ongoing treatments. The focus on addressing stimulus over- selectivity is very important in that the “endophentypic” deficits in autism need to be taught to in order to build a foundation for the learning of the more obvious skills which need to be taught. I also want to emphasize the value of the rigorous methodologic testing of teaching tools such as this as children with ASD are being taught often with untested and too often poorly conceived “treatments“.

Elizabeth Kalmanov, MA, CCC-SLP

I would like to express my support of the ImagiRation application MITA, which is designed to improve the visual and language skills of young children as well as children with Autism Spectrum Disorders.  I have had an opportunity to use this application, in conjunction with the language therapy, with preschool children who were diagnosed with moderate to severe language delays.  The application served both as therapy and a reward and was well received by the students.  At the end of one year, I have been able to track not only improvements in the mean length of utterance of the users, but also in their fine motor ability.  The application is entertaining, intuitive, accessible to educators, therapists and parents, and is rooted in extensive and well-documented research.  Data tracking is automatic and kept for each user.  I highly recommend this software to both parents and professionals.

William J. McIlvane, Ph.D.
Director, University of Massachusetts Medical School (UMMS)
Intellectual and Developmental Disabilities Research Center
Professor of Psychiatry & Pediatrics, UMMS

The letter is intended to convey my interest in and support for the efforts of the Imagiration development group. After reviewing your materials and talking with you in our recent meeting, I concluded that your group is doing meritorious work that is aligned well with recent directions of my research group at the University of Massachusetts Medical School’s Eunice Kennedy Shriver Center.

I was both surprised and impressed by the investment of intellectual and personnel resources represented in your materials. I think that they have merit not only for the purposes for which you developed them but also for purposes of advancing research on aspects of attention, memory, and executive functioning. Indeed, I think that one could develop an NIH-competitive project around them, addressing specifically the degree to which experience with your materials would lead to more general improvements in managing complex information-processing tasks.

Good luck with your work and efforts to secure support for continuation of your interesting development program.

Enter your pledge amount

£

CONTINUE
  • 5 Backers

    We really appreciate your support! We will email you a report of our findings once the project is completed.

  • 6 Backers

    Thank you e-postcard: We really appreciate your support and will thank you by sending a personal e-postcard from the whole team at ImagiRation + the above.

  • 8 Backers

    Signed scientific-journal article with published research: For lovers of science, we will mail you the scientific journal article with the published MITA findings, signed by the research team Dr. Vyshedskiy, Rita Dunn, and Jonah Elgart

  • 9 Backers
    Limit of 100 — 91 remaining

    Seminar tickets and signed book: Dr. Vyshedskiy will be hosting an exciting presentation on the research team’s findings at Boston University. You will be one of the first people to know and understand the results of the MITA study, how it works and how it changes the brain function. This will be arranged in coordination with the publication of the study. Dates are to be confirmed, but most likely the event will take place in early 2017. If there is high demand for additional seminars in other locations, we will do our best to accommodate them

  • 2 Backers
    Limit of 50 — 48 remaining

    Seminar tickets and entry to drinks reception: After Dr. Vyshedskiy’s presentation of the results, he and the research team will be hosting a drinks reception. This is a great opportunity to talk to the ImagiRation team and be a part of the critical conversation on autism research.

  • Backers
    Limit of 10 — 10 remaining

    Dinner with the scientists in Boston: The truly curious and inquisitive can join the research team (bring a +1!) Dr. Vyshedskiy, Rita Dunn and Jonah Elgart in Boston. This will be a brilliant opportunity to talk in depth with leading scientists about autism research. In addition, you will receive signed published articles, along with a signed copy of Dr. Vyshedskiy's book "On the Origin of the Human Mind."

  • Backers
    Limit of 1 — 1 remaining

    Fund the project: If you have been touched by autism and are in a position to provide the funding for this whole project, you can either pledge here or email us directly at hello@crowd.science

2 Comments

  1. Raul

    Is the article on the 20£ tier the same as the book of the 50£ tier?

    I can not attend the conference, but I’ll be happy to have the most extended research information. If there will be a book, I’d like it.

    So, if they are the same, I’ll be in for the 20£ tier.
    If they are not the same, please add an intermediate tier for it if possible.

    Thanks.

Leave a Reply

  1. Anonymous
    £5.00
  2. Edward Khokhlovich
    £50.00
  3. Anonymous
    £5.00
  4. Andrei Savchenko
    £50.00
  5. Mikhail Moyzeson
    £20.00
  6. tatyana makarova
    £50.00
  7. Mark Shifrin
    £50.00
  8. Konstantin Khlopenkov
    £20.00
  9. Yasha Kahn
    £50.00
  10. Anonymous
    £50.00
  11. Michael Gurevich
    £50.00
  12. Anonymous
    £100.00
  13. Iwona Read
    £5.00
  14. Francisca Martínez López
    £20.00
  15. Kelly Barrett
    £10.00
  16. HUI YA CHEN
    £10.00
  17. Razan Kattoa
    £10.00
  18. Anonymous
    £30.00
  19. Anonymous
    £20.00
  20. Raul Portales
    £20.00
  21. Anonymous
    £20.00
  22. Anonymous
    £50.00
  23. Anonymous
    £10.00
  24. Irina Sigalovsky
    £50.00
  25. Hayley Monk
    £20.00
  26. Isabel Wylie
    £10.00
  27. Anonymous
    £5.00
  28. Edwin Alegria
    £5.00
  29. Ivan Mazalov
    £100.00
  30. Ronan O'Driscoll
    £10.00
    • Terms of Agreement
      • The following Terms and Conditions constitute a legally binding agreement between Crowd.Science and Crowd.Science’s members.
      • This agreement outlines the terms and conditions that govern member use as a Campaign Owner, Campaign Funder or third party and includes anyone acting on the Campaign Owner or Campaign Funder’s behalf or with the Campaign Owner or Campaign Funder’s express or implied authority of our services at www.Crowd.Science (”Crowd.Science”).
      • It is the member’s responsibility to read and comply with these Terms and Conditions and CrowdScience’s Privacy Policy before the member registers, launches a campaign or funds a campaign.
      • The member’s use of Crowd.Science is contingent upon Crowd.Science’s Privacy Policy and these Terms and Conditions.
      • Use of Crowd.Science will be considered acceptance of Crowd.Science’s Terms and Conditions and Privacy Policy.
      • Science reserves the right to modify these Terms and Conditions and/or Privacy Policy from time to time without notice.
      • Science’s Privacy Policy may be accessed on our website
      • Amended Terms and Conditions and/or Privacy Policy will be effective immediately and the member’s continued use of Crowd.Science will constitute acceptance of such changes.
      • The member also undertake to familiarise themself with Campaign Owners and Campaign Funders must also agree and comply with the Stripe Acceptable Use Policy and the terms and conditions on other websites operated by Crowd.Science and its related and affiliated companies, to the extent that the member uses those websites. Stripe is the payment gateway which Crowd.Science uses.
      • Nothing in this Agreement creates a partnership, employment relationship or agency between the member and Crowd.Science.
      • This Agreement may not be assigned in whole or in part, to any third party without Crowd.Science’s prior written consent, and any attempt to do so will be invalid.
      • Should any part of this Agreement be held invalid or unenforceable, that portion will be construed consistent with applicable law and the remaining portions will remain in full force and effect.
      • Failure by Crowd.Science to enforce any provision of this Agreement will not be considered a waiver of the right to enforce such provision and Crowd.Science’s rights under this Agreement will survive any termination of this Agreement.
    • Member usage
      • Members warrant that Campaigns listed and information provided to Crowd.Science or other members in the registration or listing process, in any public message area (including the discussion boards and in feedback) or through any email feature are true and correct.
      • Members are solely responsible for the information that they provide on Crowd.Science.
      • Members warrant that they are 18 years of age and have capacity to enter into a legally binding contract and accept these terms and conditions.
    • Definitions
      • “Campaign” means scientific research proposal, issues or causes as registered on Crowd.Science by the Campaign Owner.
      • Campaign Deadline” means the period in which Crowd.Science decides that the Campaign Owners fundraising period expires;
      • “Campaign Owners” means individuals, groups and organisations (as approved by Crowd.Science moderators) who have registered a Campaign on Crowd.Science.
      • “Campaign Funders” means individuals, groups and organisations that fund Campaign Owners campaigns in exchange for Rewards.
      • “Campaign Reward” means items, experiences or services offered by Campaign Owners to Campaign Funders in exchange for Campaign Funders funding Campaigns.
      • “Crowd.Science” means the Crowd.Science website platform and software and includes Crowd.Science’s agents, employees, subcontractors and suppliers.
      • “Crowd.Science moderators” means a moderator approved by Crowd.Science to decide which Campaigns are eligible to raise funds on Crowd.Science.
      • “Crowd.Science’s service” means the service provided by Crowd.Science to provide an online platform for Campaign Owners to raised funds for their Campaign;
      • “Copyright” means Copyright as per the Copyright Act 1968 (Cth);
      • “Funds” means the funds raised by the Campaign Owner as provided by the Campaign Funder
      • “Force Majeure” means the occurrence of any event or circumstance beyond the reasonable control of Crowd.Science.
      • “VAT” refers to tax
      • “the member” means the Campaign Owner, Campaign Funder or third party and includes anyone acting on the behalf of a Campaign Owner or Campaign Funder or with express or implied authority.
      • “Intellectual Property Rights” means patents, Trademarks, service marks, design rights (registrable or otherwise) applications for any of the foregoing, Copyright, database rights, trade or business names and other similar rights or obligations whether registrable or not in any country (including but not limited to Australia);
      • “Trust Account” means the trust account held by the Nominated body that will hold the funds raised by the Campaign Owner from the Campaign Funders.
    • Science’s Service
      • Science is an online crowdfunding service and acts as a venue to allow members who comply with Crowd.Science’s Terms and Conditions and Policies to raise funds for their scientific proposals, or to contribute funding to scientific proposals.
      • Science allows approved Campaign Owners to list Campaigns and raise funds through offering Rewards to new and existing Campaign Funders.
    • Science has limited liability
      • Science is not directly involved in the transaction between Campaign Owners and Campaign Funders. As a result, Crowd.Science will not be liable for the control, quality, safety, morality or legality of any aspect of the Rewards listed or the truth or accuracy of the listings, the ability of Campaign Owners to sell Rewards or the ability of Campaign Funders to pay for Rewards.
      • Science cannot ensure that a Campaign Funder or a Campaign Owner will actually complete a transaction and is not liable for any loss to the Campaign Funder or Campaign Owner.
      • Science does not transfer legal ownership of Rewards from the Campaign Funder to the Campaign Owner and is not liable for any failure by the Campaign Owner to provide a Reward to the Campaign Funder.
      • Science cannot guarantee the true identity, age, and nationality of any member.
      • Science is not responsible or liable for any content (data, text, information, graphics, images, photographs, profiles, audio, video, items, and links) posted by members or third parties on Crowd.Science. Crowd.Science does not take any responsibility for any loss caused to the Campaign Owner or Campaign Funder arising directly or indirectly from any failure or delay caused by the Campaign Owner or Campaign Funder or by reason of any event or circumstance outside of the reasonable control of Crowd.Science or due to Force Majeure.
      • It is the responsibility of the Campaign Owner/Campaign Funder to take precautions to ensure that whatever computer equipment and/or software used is free from viruses, worms, Trojans and other items of a destructive nature.
      • Science shall not be liable for the interactions with any organisations and/or individuals found on or through the Crowd.Science service. This includes, but is not limited to, delivery of goods and services, and any other terms, conditions, warranties or representations associated with listings on Crowd.Science.
      • .Crowd.Science cannot be held liable for the actions of a Campaign Owner; Campaign Owners are wholly responsible for fulfilling obligations both implied and stated in any campaign listing they create.
      • Science does not oversee the performance or punctuality of Campaigns.
      • Science reserves the right to cancel a campaign listing and cancel all pledged payments at any time for any reason.
      • Science reserves the right to remove a campaign listing from public listings for any reason.
      • Science is not responsible for any damage or loss incurred as a result of any dealings on the Crowd.Science platform.
      • Science is under no obligation to become involved in disputes between Campaign Funders and Campaign Owners, or between site members and any third party. In the event of a dispute, you release Crowd.Science employees, partners and successors in rights from claims, damages and demands of every kind, known or unknown, suspected or unsuspected, disclosed or undisclosed, arising out of or in any way related to such disputes and our service.
      • Science cannot guarantee the performance or reliability of the STRIPE online payment service. Additionally, because of occasional failures of some credit cards, Crowd.Science cannot guarantee the full receipt of the total funds pledged to a Campaign Owner’s campaign.
      • Science cannot guarantee the full receipt of pledged funds Campaign Funders due to occasional failures when capturing funds from debit and credit cards.
      • While Crowd.Science may provide basic moderation to listed Campaigns, Crowd.Science is under no obligation to do so, and Campaign Funders are responsible for due diligence before pledging any funding to Campaign Owners.
      • This limitation of liability section shall prevail over any conflicting or inconsistent provision contained in these Terms and Conditions.
    • How Campaigns Work
      • Campaign Owners register as members on Crowd.Science.
      • Campaign Owners register their Campaign on Crowd.Science for approval by Crowd.Science.
      • Science moderators assess the Campaign.
      • If Crowd.Science moderators accept the Campaign Owners Campaign, Crowd.Science will register the Campaign and open the Campaign to receive funds from Crowd.Science in exchange for Rewards as provided to Campaign Funders by the Campaign Owners (if applicable).
      • All funds are collected for Campaign Owners from Campaign Funders through the Stripe online payment service.
      • Campaign Funds are then transferred into the Campaign Owner for the Campaign Owner to then transfer into their Nominated Account in line with their university policy.
      • Science collects and transfers these pledged funds to the Campaign Owner at the Campaign Deadline if the campaign goal has been reached.
    • Campaign Owner and Campaign Funder Obligation
      • By launching a Campaign on Crowd.Science, the Campaign Owner agrees that all funds raised will be used for conducting the research proposed in their campaign.
      • If more funds are raised than the goal specified, the Campaign Owner must use the funding for conducting related research or refund the excess to the backers.
      • As a Campaign Owner, Campaign Funder or member you accept and agree that Crowd.Science is not responsible for the transfer of funds after Crowd.Science has transferred funds to the Campaign Owner.
      • Science is under no obligation to become involved in disputes between backers and researchers or between site members and any third party
      • Science does not oversee the performance or punctuality of projects.
      • Science cannot be held liable for the actions of a researcher, researchers are wholly responsible for fulfilling obligations both implied and stated in any project listing they create.
      • [Funders] It is solely your choice to contribute to a project and contributing to a project does not give you any rights in or to that project
      • [Funders] Any perks offered to you are between you and the researcher only and Crowd.Science does not guarantee that they will be of satisfaction to you.
    • Campaign Rewards
      • By listing a Reward on Crowd.Science the Campaign Owner warrants that all aspects of the Reward comply with Crowd.Science’s published policies.
      • The Campaign Owner warrants that the Reward may be legally sold.
      • The Campaign Owner must accurately describe the Rewards and all terms of sale in the Campaign Description and the Reward Description.
      • Reward Descriptions may only include text descriptions, graphics, pictures, videos, photographs and other content relevant to the sale of that Reward.
      • Rewards must accurately and completely describe the item(s) or experiences on offer. If the available quantity of the Reward is more than one or unlimited, all items and/or experiences listed in that Reward tier must be identical.
      • Each unique Reward must have its own listing as a new Reward.
      • All Campaign Owners are urged to outline seller policies for their Campaigns. These policies may include, for example, shipping, returns, payment and selling policies.
      • Campaign Owners must create reasonable policies in good faith and must abide by such policies. All seller policies must comply with Crowd.Science’s site-wide policies.
      • Campaign Owners are responsible for enforcing their own reasonable seller policies.
      • Science reserves the right to request that a Campaign Owner modify a seller policy.
      • All Reward sales are binding on the Campaign Owner.
      • The Campaign Owner is wholly responsible for meeting any obligation or Reward stated or implied in their campaign. Crowd.Science is not responsible for the delivery of Rewards stated in campaigns. Campaign Funders should contact the Campaign Owner if the delivery terms are not clearly stated in the project description.
      • The Campaign Owner is obligated to provide the Reward(s) or otherwise complete the transaction with the Campaign Funder.
    • Fees Payable to Crowd.Science
      • Registering as a member and setting up a Campaign on Crowd.Science is free.
      • Science charges fees to Campaign Owners at the conclusion of the campaign or whenever the Campaign Owner chooses to collect the pledged funds. Funds can only be collected once the campaign has reached its goal.
      • Science will initiate a capture of all funds from Campaign Funders and transfer the funds to the Campaign Owner (minus the Crowd.Science fees).
      • Science charges a service fee of 5%, which is deducted from the total amount of funds raised at the end of the campaign.
      • Science charges a transaction fee for Credit / Debit Card on Crowd.Science 2% + 30p per transaction (UK) to cover costs incurred from the stripe payment gateway.
      • There is a 7 – 10 business day processing period (after the end of a Campaign) in which supporters who have had their pledges declined are invited to resubmit their pledge.
      • Science may change fee policies and the fees for services.
      • Science may choose to temporarily change our fees policy and the fees for our services for promotional events (for example, free service days) and such changes are effective when we post the temporary promotional event.
      • If Crowd.Science introduces a new service, the fees for that service are effective at the launch of the service.
      • Unless otherwise stated, all fees are quoted in the currency of the project.
      • The member is responsible for paying all fees associated with using our services and all applicable taxes (including any goods and services or value added taxes, which will be added to amounts billed to you, if applicable).
      • The member should consider Crowd.Science fees when determining the funding goal of Campaigns.
      • The campaign owner is responsible for paying any taxes that may be required e.g. if the funding is paying for salaries.
    • Stripe Payment Gateway
      • Campaigners and contributors must agree to comply with Stripe Terms and Conditions.
    • Refunds
      • Science transfers the funds to the Campaign Owner after the campaign deadline.
      • Funds collected through the Crowd.Science platform are non-refundable and Crowd.Science is not responsible for issuing refunds to Campaign Funders
      • Campaign Funders may initiate refunds at their own discretion.
      • If, for any reason, Crowd.Science is required to refund monies to Campaign Owners, the Campaign Owner will fully compensate Crowd.Science for the amount refunded as well as any associated costs, including but not limited to transaction or administrative costs.
      • The member agrees that any attempt to obtain a refund without first having obtained prior written consent to refund shall entitle Crowd.Science to deactivate the member’s account unless and/or until such time as the fees are repaid or a credit or refund is agreed with Crowd.Science.
    • Communications with Crowd.Science
      • Communications between the Member and Crowd.Science are to be in electronic form.
      • The member consents to receive communications and notice from Crowd.Science electronically and agrees that all terms and conditions, agreements, notices, disclosures, and other communications that Crowd.Science satisfy any legal requirement that such communications would satisfy if it were in writing.
    • Tax and legal compliance
      • In addition to these terms and conditions the member must familiarise them self with, and comply with the Policies, domestic laws (including common law), country legislation, international laws, statutes, ordinances and regulations regarding use of Crowd.Science  services including listing and supporting Campaigns.
      • Campaign Owners should be aware that funds raised using Crowd.Science could be taxable income. It is the Campaign Owner’s responsibility to declare the funds and comply with local tax laws.
      • Campaign Owners alone, and not Crowd.Science, are responsible for ensuring that the campaign listing and any other activities conducted on the Crowd.Science website are lawful.
      • Campaign Owners must ensure that they comply with all applicable laws in UK and all other countries.
      • Campaign Owners must also ensure that they strictly comply with these term and conditions and the policies, which form part of the agreement.
    • Dispute Resolution
      • The member shall attempt to resolve all disputes arising out of these Terms and Conditions in a spirit of cooperation without formal legal proceedings.
      • Any dispute which cannot be resolved and other than injunctive relief shall be subject to mediation upon written demand of the member to Crowd.Science and any notice of dispute shall be provided within seven (7) days of the dispute arising.
    • Governing Law and Jurisdiction
      • These terms and conditions are governed in all respects by the laws of the United Kingdom and any action arising under them or in any way connected with the Crowd.Science service may be brought only in a court in the United Kingdom, subject to any law, which is expressly inconsistent with this.
      • The members irrevocably agree that the courts of United Kingdom are to have exclusive jurisdiction to settle any disputes which may arise.
    • Third Party Site
      • The site may permit [campaigners] to link to other website or resources on the internet and other third party websites. Crowd.Science is not responsible for the content, functions, accuracy, privacy policy, legality, appropriateness or any other aspect of any external links or sited resources.
      • Science is not responsible or liable directly or indirectly for any claims, demands, damages against Crowd.Science arising from or in connection with any damage or loss caused or alleged by on in connection with your use of or reliance on any such contect, goods or services available through any external links or resources
    • Prohibited Use Of Crowd.Science
      • Science staff and appointed members may moderate campaigns and other content (data, text, information, graphics,   images, photographs, profiles, audio, video, items, and links) on the Crowd.Science platform.

    The member is solely responsible for the member’s conduct and activities on the Crowd.Science venue and any and all data, text, information, graphics, images, photographs, profiles, audio, video, items, and links (together, “Content”) that are submitted, posted, and displayed on the Crowd.Science venue.The member’s content and use of Crowd.Science shall not: be false, inaccurate or misleading; be fraudulent or involve the sale of illegal, counterfeit or stolen items; infringe upon any third-party’s copyright, patent, trademark, trade secret or other proprietary or intellectual property rights or rights of publicity or privacy; violate this Agreement, any site policies, any site guidelines, or any applicable laws, statute, ordinance or regulation (including, but not limited to, those governing export control, consumer protection, unfair competition, anti-discrimination or false advertising); contain items that have been identified by your local government as hazardous to consumers and therefore subject to a recall; be defamatory, libellous, unlawfully threatening, unlawfully harassing, or impersonate or intimidate any person (including Crowd.Science staff or other users), or falsely state or otherwise misrepresent affiliation with any person, through for example, the use of similar email address, nicknames, or creation of false account(s) or any other method or device; be obscene or contain pornography, child pornography or explicit content; contain or transmit any code of a destructive nature that may damage, detrimentally interfere with, surreptitiously intercept or expropriate any system, data or personal information; modify, adapt or hack Crowd.Science or modify another website so as to falsely imply that it is associated with Crowd.Science; appear to create liability for Crowd.Science or cause Crowd.Science to lose (in whole or in part) the services of Crowd.Science’s ISPs or other suppliers; link directly or indirectly, refer or contain descriptions of goods, experiences or services that are prohibited under this Agreement, the Privacy Policy, or other policy documents as posted on Crowd.Science; Members must not list any Reward on Crowd.Science (or consummate any transaction that was initiated using Crowd.Science’s service) that, by paying to Crowd.Science the transaction or fee, could cause Crowd.Science to violate any applicable law, statute, ordinance or regulation, or that violates these Terms and Conditions; Crowd.Science reserves the right to terminate a member’s access to Crowd.Science if Crowd.Science suspects, after investigation, that they have misused the Crowd.Science service, violated the terms of this Agreement, or have otherwise used the Crowd.Science service to conduct any fraudulent or illegal activity or breached Crowd.Science’s Terms and Conditions; In the event an account is suspended or terminated for breach of this Agreement (in each case as determined in Crowd.Science’s sole discretion), Crowd.Science may suspend or terminate the account associated with such breach and any or all other accounts held by you or your affiliates, and your breach shall be deemed to apply to all such accounts.

Enter your pledge amount

£

CONTINUE
  • 5 Backers

    We really appreciate your support! We will email you a report of our findings once the project is completed.

  • 6 Backers

    Thank you e-postcard: We really appreciate your support and will thank you by sending a personal e-postcard from the whole team at ImagiRation + the above.

  • 8 Backers

    Signed scientific-journal article with published research: For lovers of science, we will mail you the scientific journal article with the published MITA findings, signed by the research team Dr. Vyshedskiy, Rita Dunn, and Jonah Elgart

  • 9 Backers
    Limit of 100 — 91 remaining

    Seminar tickets and signed book: Dr. Vyshedskiy will be hosting an exciting presentation on the research team’s findings at Boston University. You will be one of the first people to know and understand the results of the MITA study, how it works and how it changes the brain function. This will be arranged in coordination with the publication of the study. Dates are to be confirmed, but most likely the event will take place in early 2017. If there is high demand for additional seminars in other locations, we will do our best to accommodate them

  • 2 Backers
    Limit of 50 — 48 remaining

    Seminar tickets and entry to drinks reception: After Dr. Vyshedskiy’s presentation of the results, he and the research team will be hosting a drinks reception. This is a great opportunity to talk to the ImagiRation team and be a part of the critical conversation on autism research.

  • Backers
    Limit of 10 — 10 remaining

    Dinner with the scientists in Boston: The truly curious and inquisitive can join the research team (bring a +1!) Dr. Vyshedskiy, Rita Dunn and Jonah Elgart in Boston. This will be a brilliant opportunity to talk in depth with leading scientists about autism research. In addition, you will receive signed published articles, along with a signed copy of Dr. Vyshedskiy's book "On the Origin of the Human Mind."

  • Backers
    Limit of 1 — 1 remaining

    Fund the project: If you have been touched by autism and are in a position to provide the funding for this whole project, you can either pledge here or email us directly at hello@crowd.science